Acute stress ulceration prophylaxis: Point prevalence surveys in intensive care units in Victoria, 1997 and 2005

Critical Care and Resuscitation

Volumn 10, Issue 1, 2008, Pages 15-18

  Robertson, Megan S ^a,b   Wilson, Stuart J ^c   Cade, John F ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST;

HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; PREVALENCE; QUESTIONNAIRE; VICTORIA;

CRITICAL CARE; HISTAMINE H2 ANTAGONISTS; HUMANS; INTENSIVE CARE UNITS; PREVALENCE; SURVEYS AND QUESTIONNAIRES; VICTORIA;

EID: 70350517298     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 1 Harris S, Bone R, Ruth W. Gastrointestinal haemorrhage in patients in a respiratory intensive care unit. Chest 1977; 72: 301-4.
2. 2 Schuster, D, Rowley H, Feinstein S, et al. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 1984; 76: 623-30.
3. 3 Chamberlain C. Acute hemorrhagic gastritis. Gastroenterol Clin North Am 1993; 22: 843-73.
4. 4 Hillman K. Acute stress ulceration. Anaesth Intensive Care 1985; 13: 230-40.
5. 5 Wyncoll D, Roberts P, Beale R, McLuckie A. H2 blockers in the intensive care unit: ignoring the evidence? Telephone survey. BMJ 1997; 314: 1013.
6. 6 Cook D, Fuller H, Guyatt G, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330: 377-81.
7. 7 Lucas C, Sugawa C, Riddle J, et al. Natural history and surgical dilemma of “stress” gastric bleeding. Arch Surg 1971; 102: 266-73.
8. 8 Bumaschny E, Doglio G, Pusajo J, et al. Postoperative acute gastrointestinal tract haemorrhage and multiple-organ failure. Arch Surg 1988; 123: 722-6.
9. 9 Daley R, Rebuck J, Welage L, Rogers B. Prevention of stress ulceration: current trends in critical care. Crit Care Med 2004; 32: 2008-13.
10. 10 Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998; 338: 791-7.
11. 11 Wolfe MM, Sachs G. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 2000; 118: S9-31.
12. 12 Phillips J, Metzler M, Palmieri T, et al. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med 1996; 24: 1793-800.
13. 13 Levy M, Seelig C, Robinson N, Ranney J. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997; 42: 1255-9.
14. 14 Phillips J, Metzler M, Huckfeldt R, Olsen K. A multicenter, prospective, randomised clinical trial of continuous infusion i.v ranitidine vs omeprazole suspension in the prophylaxis of stress ulcers. Crit Care Med 1998; 28: 101A.
15. 15 Lasky MR, Metzler MH, Phillips JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma 1998; 44: 527-33.
16. 16 Tsai WL, Poon SK, Yu HK, et al. Nasogastric lansoprazole is effective in suppressing gastric acid secretion in critically ill patients. Aliment Pharmacol Ther 2000; 14: 123-7.
17. 17 Conrad S, Gabrielli A, Margolis B, et al. Randomised, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005; 33: 760-5.